Pacira BioSciences' Short-term Investments fell 5249.1% to $98.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.7 million, marking a year-over-year decrease of 5249.1%. This contributed to the annual value of $207.8 million for FY2024, which is 6589.72% up from last year.
Latest data reveals that Pacira BioSciences reported Short-term Investments of $98.7 million as of Q3 2025, which was down 5249.1% from $145.4 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Short-term Investments peaked at $559.8 million during Q3 2021, and registered a low of $70.8 million during Q4 2021.
Moreover, its 5-year median value for Short-term Investments was $184.5 million (2022), whereas its average is $222.2 million.
In the last 5 years, Pacira BioSciences' Short-term Investments tumbled by 8320.37% in 2021 and then skyrocketed by 16049.61% in 2022.
Quarter analysis of 5 years shows Pacira BioSciences' Short-term Investments stood at $70.8 million in 2021, then skyrocketed by 160.5% to $184.5 million in 2022, then crashed by 32.1% to $125.3 million in 2023, then skyrocketed by 65.9% to $207.8 million in 2024, then crashed by 52.49% to $98.7 million in 2025.
Its last three reported values are $98.7 million in Q3 2025, $145.4 million for Q2 2025, and $210.0 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value